Akebia Therapeutics (AKBA) Priced

Biotech developing a breakthrough anemia treatment with a once-daily oral dose.

Health Care - Biotechnology

IPO Performance
Latest Trade $10.15 0.00 (0.0%)
First Day Return 57.1%
Return from IPO -40.3%
 
Akebia Therapeutics IPO News more
  • .
IPO Data
IPO File Date 02/14/2014
Offer Price $17.00
Price Range $14.00 - $17.00
Offer Shares (mm) 5.9
Deal Size ($mm) 100
 
IPO Data
IPO Date 03/19/2014
Offer Price $17.00
Price Range $14.00 - $17.00
Offer Shares (mm) 5.9
Deal Size ($mm) $100
 
Underwriters
more
Business Overview
Biotech developing a breakthrough anemia treatment with a once-daily oral dose.
Biotech developing a breakthrough anemia treatment with a once-daily oral dose.
more
Company Data
Headquarters Cambridge, MA
Founded 2007
Employees 28
Website www.akebia.com
 

Performance vs. IPO Index (IPOUSA)